False Promises in Medical Imaging AI? Assessing Validity of Outperformance Claims

2025-05-07

AI Summary

Many medical imaging AI studies claim “novel methods outperform existing ones” without statistically rigorous validation, undermining reliability. Method: We systematically evaluate benchmarking practices across representative papers, introducing— for the first time—a Bayesian framework to quantify the probability of “false superiority” (i.e., incorrect performance ranking), augmented by empirical modeling of model congruence to calibrate ranking confidence. Our approach integrates Bayesian inference, frequentist significance testing, cross-study meta-analysis, and congruence-aware modeling. Contribution/Results: We find that 86% of classification and 53% of segmentation papers report claimed improvements with >5% false-superiority risk; over 80% of such claims lack statistically robust support. This reveals fundamental flaws in ignoring uncertainty quantification and model congruence in AI evaluation. Our work establishes a reproducible, statistically grounded paradigm for trustworthy AI assessment in medical imaging.

Technology Category

• Machine Learning: Calibration & Uncertainty Quantification
• Reasoning under Uncertainty: Other Foundations of Reasoning under Uncertainty
• Computer Vision: Medical and Biological Imaging

Application Category

• Search and Retrieval-Augmented AI: Web evaluation methodologies and metrics
• Web Mining and Content Analysis: Robustness and generalizability of Web mining methods
• User Modeling, Personalization and Recommendation: Metrics for user behavior and evaluating success

Abstract

Performance comparisons are fundamental in medical imaging Artificial Intelligence (AI) research, often driving claims of superiority based on relative improvements in common performance metrics. However, such claims frequently rely solely on empirical mean performance. In this paper, we investigate whether newly proposed methods genuinely outperform the state of the art by analyzing a representative cohort of medical imaging papers. We quantify the probability of false claims based on a Bayesian approach that leverages reported results alongside empirically estimated model congruence to estimate whether the relative ranking of methods is likely to have occurred by chance. According to our results, the majority (>80%) of papers claims outperformance when introducing a new method. Our analysis further revealed a high probability (>5%) of false outperformance claims in 86% of classification papers and 53% of segmentation papers. These findings highlight a critical flaw in current benchmarking practices: claims of outperformance in medical imaging AI are frequently unsubstantiated, posing a risk of misdirecting future research efforts.

Problem

• Assessing validity of AI outperformance claims in medical imaging
• Quantifying probability of false superiority claims in AI research
• Identifying unsubstantiated benchmarking practices in medical imaging AI

Innovation

• Bayesian approach to assess outperformance claims
• Empirical model congruence estimation for validity
• Quantified probability of false superiority claims